Erenumab-话题@MedSci

#Erenumab#

8篇内容 | 1464人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2200093, encodeId=3119220009377, content=<a href='/topic/show?id=03cf954668b' target=_blank style='color:#2F92EE;'>#酒渣鼻#</a> <a href='/topic/show?id=d97968389e6' target=_blank style='color:#2F92EE;'>#玫瑰痤疮#</a> <a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a>, objectTitle=治疗玫瑰痤疮，每4周一针即可！JAMA子刊：有效缓解潮红和红斑, objectType=article, longId=822894, objectId=f58382289424, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/filling-medical-history-XZB9RVX.jpg, objectUrl=/article/show_article.do?id=f58382289424, replyNumber=0, likeNumber=0, createdTime=2024-04-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=f58382289424, moduleTitle=治疗玫瑰痤疮，每4周一针即可！JAMA子刊：有效缓解潮红和红斑, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f58382289424)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2175204, encodeId=3df121e520467, content=<a href='/topic/show?id=1ffc2e613ae' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=c9b710602185' target=_blank style='color:#2F92EE;'>#偏头痛#</a></a> <a href='/topic/show?id=aa308e8307e' target=_blank style='color:#2F92EE;'>#药物研发#</a> <a href='/topic/show?id=943e8085574' target=_blank style='color:#2F92EE;'>#肉毒杆菌毒素#</a> <a href='/topic/show?id=6f6545546c' target=_blank style='color:#2F92EE;'>#CGRP#</a> <a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a> <a href='/topic/show?id=8d9f15481b0' target=_blank style='color:#2F92EE;'><a href='/topic/show?id=4a51106261f1' target=_blank style='color:#2F92EE;'>#rimegepant#</a></a> <a href='/topic/show?id=fa8718068f5' target=_blank style='color:#2F92EE;'>#Ubrogepant#</a>, objectTitle=偏头痛药物的市场和研发管线综述, objectType=article, longId=801980, objectId=1025801980c8, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20231216/32921b92a05c44bb9413033ffa07f1cf.jpg, objectUrl=/article/show_article.do?id=1025801980c8, replyNumber=0, likeNumber=146, createdTime=2023-12-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=1025801980c8, moduleTitle=偏头痛药物的市场和研发管线综述, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1025801980c8)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1435995, encodeId=5a8314359952e, content=<a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a>, objectTitle=JNNP:Erenumab对发作性偏头痛患者功能结果的影响：LIBERTY研究的结果, objectType=article, longId=209017, objectId=5acf20901eaa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5acf20901eaa, replyNumber=0, likeNumber=124, createdTime=2021-03-27, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5acf20901eaa, moduleTitle=JNNP:Erenumab对发作性偏头痛患者功能结果的影响：LIBERTY研究的结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5acf20901eaa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435994, encodeId=09831435994bc, content=<a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a>, objectTitle=JNNP:Erenumab对发作性偏头痛患者功能结果的影响, objectType=article, longId=205811, objectId=eb4e205811ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb4e205811ce, replyNumber=0, likeNumber=125, createdTime=2021-01-18, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb4e205811ce, moduleTitle=JNNP:Erenumab对发作性偏头痛患者功能结果的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb4e205811ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435993, encodeId=7809143599318, content=<a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a>, objectTitle=Neurology：Erenumab预防偏头痛的血管安全性, objectType=article, longId=185009, objectId=84ed18500981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84ed18500981, replyNumber=0, likeNumber=0, createdTime=2019-12-22, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84ed18500981, moduleTitle=Neurology：Erenumab预防偏头痛的血管安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84ed18500981)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435992, encodeId=202b143599291, content=<a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a>, objectTitle=每年5000英镑的治疗费用，诺华Erenumab偏头痛药物未达到NICE推荐标准, objectType=article, longId=180137, objectId=a97d18013e74, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a97d18013e74, replyNumber=0, likeNumber=70, createdTime=2019-09-29, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a97d18013e74, moduleTitle=每年5000英镑的治疗费用，诺华Erenumab偏头痛药物未达到NICE推荐标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a97d18013e74)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435991, encodeId=5742143599132, content=<a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a>, objectTitle=Neurology:Erenumab治疗偏头痛效果显著, objectType=article, longId=164860, objectId=5c7b1648600f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c7b1648600f, replyNumber=0, likeNumber=0, createdTime=2019-04-24, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c7b1648600f, moduleTitle=Neurology:Erenumab治疗偏头痛效果显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c7b1648600f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435990, encodeId=cded14359909f, content=<a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a>, objectTitle=Lancet：Erenumab——难治性偏头痛患者的福音, objectType=article, longId=151686, objectId=638b1516864f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=638b1516864f, replyNumber=0, likeNumber=85, createdTime=2018-10-25, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=638b1516864f, moduleTitle=Lancet：Erenumab——难治性偏头痛患者的福音, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=638b1516864f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435989, encodeId=2f6d1435989e3, content=<a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a>, objectTitle=诺华CGRPR单抗Erenumab获批成为欧洲偏头痛预防药物, objectType=article, longId=145637, objectId=acc714563eea, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=acc714563eea, replyNumber=0, likeNumber=86, createdTime=2018-08-03, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=acc714563eea, moduleTitle=诺华CGRPR单抗Erenumab获批成为欧洲偏头痛预防药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acc714563eea)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1435988, encodeId=0e4c143598891, content=<a href='/topic/show?id=69726941bc' target=_blank style='color:#2F92EE;'>#Erenumab#</a>, objectTitle=NEJM：降钙素基因相关肽受体单克隆抗体Erenumab对偏头痛的预防作用, objectType=article, longId=121860, objectId=5d6212186033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5d6212186033, replyNumber=0, likeNumber=78, createdTime=2017-12-02, rootId=0, userName=zhouqu_8, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5d6212186033, moduleTitle=NEJM：降钙素基因相关肽受体单克隆抗体Erenumab对偏头痛的预防作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5d6212186033)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Erenumab

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#酒渣鼻# #玫瑰痤疮# #Erenumab#

治疗玫瑰痤疮，每4周一针即可！JAMA子刊：有效缓解潮红和红斑

2024-04-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#偏头痛# #药物研发# #肉毒杆菌毒素# #CGRP# #Erenumab# #rimegepant# #Ubrogepant#

偏头痛药物的市场和研发管线综述

2023-12-16发表于威斯康星

zhouqu_8 (审核中...)

前往app查看评论内容

#Erenumab#

JNNP:Erenumab对发作性偏头痛患者功能结果的影响：LIBERTY研究的结果

2021-03-27

zhouqu_8 (审核中...)

前往app查看评论内容

#Erenumab#

JNNP:Erenumab对发作性偏头痛患者功能结果的影响

2021-01-18

zhouqu_8 (审核中...)

前往app查看评论内容

#Erenumab#

Neurology：Erenumab预防偏头痛的血管安全性

2019-12-22

zhouqu_8 (审核中...)

前往app查看评论内容

#Erenumab#

每年5000英镑的治疗费用，诺华Erenumab偏头痛药物未达到NICE推荐标准

2019-09-29

zhouqu_8 (审核中...)

前往app查看评论内容

#Erenumab#

Neurology:Erenumab治疗偏头痛效果显著

2019-04-24

zhouqu_8 (审核中...)

前往app查看评论内容

#Erenumab#

Lancet：Erenumab——难治性偏头痛患者的福音

2018-10-25

zhouqu_8 (审核中...)

前往app查看评论内容

#Erenumab#

诺华CGRPR单抗Erenumab获批成为欧洲偏头痛预防药物

2018-08-03

zhouqu_8 (审核中...)

前往app查看评论内容

#Erenumab#

NEJM：降钙素基因相关肽受体单克隆抗体Erenumab对偏头痛的预防作用

2017-12-02

科室
- - 订阅+
  - 更多科室
工具
服务